molnupiravir
E1361801
UNEXPLORED
Molnupiravir is an oral antiviral medication used to treat COVID-19 by inhibiting replication of the SARS-CoV-2 virus.
All labels observed (1)
| Label | Occurrences |
|---|---|
| molnupiravir canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T19157788 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: molnupiravir Context triple: [Ridgeback Biotherapeutics, developedProduct, molnupiravir]
-
A.
velpatasvir
Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
-
B.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
C.
Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
-
D.
REGN-COV2
REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
-
E.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: molnupiravir Target entity description: Molnupiravir is an oral antiviral medication used to treat COVID-19 by inhibiting replication of the SARS-CoV-2 virus.
-
A.
velpatasvir
Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
-
B.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
C.
Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
-
D.
REGN-COV2
REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
-
E.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.